Serotypes of respiratory tract isolates of Streptococcus pneumoniae from Jamaican children

International Journal of Infectious Diseases

Volumn 7, Issue 1, 2003, Pages 29-34

  Allen, Upton D ^a   Thomas, Sonia ^b   Carapetis, Jonathan ^a,c   Henry, Sonia ^b   Wasfy, Samia ^a   Lovgren, Marguerite ^d   Richardson, Susan ^a   Low, Donald E ^e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Bustamante Hospital for Children   (Jamaica)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d National Centre for Streptococcus   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; HUMAN; INFANT; JAMAICA; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PENICILLIN RESISTANCE; RESPIRATORY SYSTEM; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 0347926325     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90039-7     Document Type: Article

References (45)

1. Anonymous. Pneumococcal vaccines: WHO position paper. Weekly Epidemiol Rec 1999; 74:177-183.
2. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases, 25th edn. Elk Grove Village, IL: American Academy of Pediatrics; 2000:452-460.
3. Long SS, Henretig FR, Teter MJ, McGowen KL. Nasopharyngeal flora and acute otitis media. Infect Immun 1983; 41:987-991.
4. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997; 175:1440-1445.
5. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995; 127:533-537.
6. Matsro TD, Ghafoor A, Nomani NK, et al. Antimicrobial resistance of pneumococci in children with acute respiratory tract infection in Pakistan. Lancet 1991; 337:156-159.
7. Lehmann D, Gratten M, Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J 1997; 16:297-305.
8. Lloyd-Evans N, O'Dempsey TJD, Baldeh I, et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 1996; 15:866-871.
9. Gray BM, Converse GM III, Dillon HC, Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. J Infect Dis 1980; 142:923-933.
10. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis media. Pediatr Infect Dis J 2000; 19:S79-S88.
11. Leech AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997; 24:356-362.
12. Ruoff KL, Whiley RA, Beighton D, et al. Streptococcus. In: Murray PR, ed. Manual of clinical microbiology, 7th edn. Washington, DC: ASM Press, 1996:283-296.
13. National Committee for Clinical Laboratory Standards. Methods for dilution susceptibility tests for bacteria that grow anaerobically. Approved standard, 5th edn. NCCLS document M7-A4. Wayne PA: NCCLS, 2000.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS document M100-S9, Vol. 19, No. 1. Wayne, PA: NCCLS, 1999:90-91.
15. Facklam RR, Washington JA II. Streptococcus and related catalase-negative Gram positive cocci. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadom HJ, eds. Manual of clinical microbiology, 5th edn. Washington: American Society for Microbiology, 1991:238-257.
16. Centers for Disease Control and Prevention. Epi Info, Version 6. Atlanta, GA: CDC, 1994.
17. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, ed. 2000 Redbook. Report of the Committee on Infectious Diseases, 25th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2000:452-460.
18. Butler JC, Hofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J Infect Dis 1996; 174:986-993.
19. Centers for Disease Control and Prevention. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 1996; 45(RR-1):1-20.
20. Heubner RE, Wasas AD, Klugman KP, Pediatric Study Group. Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg. South Afric Med J 2000; 90:1116-1121.
21. Fedson DS. Pneumococcal conjugate vaccination for adults: why it's important for children. Pediatr Infect Dis J 2000; 19:183-186.
22. Rubin LG. Pneumococcal vaccine. Pediatr Clin North Am 2000; 47:269-285.
23. Soewignjo S, Gessner BD, Sutanto A, et al. Streptococcus pneumoniae nasopharyngeal carriage prevalence, serotype distribution, and resistance patterns among children on Lombok Island, Indonesia. Clin Infect Dis 2001; 32:1039-1043.
24. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100-121.
25. Mastro TD, Nasreen KN, Ishaq Z, et al. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J 1993; 12:824-830.
26. Allen U, Johnson B, Henry S, Fuite L, Chan F. Antibiotic susceptibility of pneumococcal isolates among Jamaican children [Abstract E26]. In: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco. Washington, DC: American Society for Microbiology, 1995.
27. Whitney CG, Fraley MM, Haldler J, et al. Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-1927.
28. Kertesz DA, Di Fabio JL, de Cunto Brandileone MC, et al. Invasive Streptococcus pneumoniae infection in Latin American children; results of the Pan American Health Organization Surveillance study. Clin Infect Dis 1998; 26:1355-1361.
29. Kellner JD, Ford-Jones EL. Streptococcus pneumoniae carriage in children attending 59 Canadian children care centers. Toronto Child Care Centre Study Group. Arch Pediatr Adolesc Med 1999; 153:495-502.
30. Skull S, Shelby-James T, Morris P, et al. Streptococcus pneumoniae antibiotic resistance in Northern Territory children in day care. J Pediatr Child Health 1999; 35:466-471.
31. Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992; 15:95-98.
32. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995; 127:533-537.
33. Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in the pneumococcal conjugate vaccines. J Infect Dis 1996; 174:1352-1355.
34. Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J 2000; 19:S57-S65.
35. Klugman KP, Koornof HJ, Kuhnle V. Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Child 1986; 140:1186-1190.
36. Arason VA, Kristinsson KA, Sigurdsson JA, Stefamsddottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross-sectional prevalence study. BMJ 1996; 313:387-391.
37. Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis 1996; 22:143-145.
38. Abdel-Haq N, Abuhammour W, Asmar B, Thomas R, Dabbagh S, Gonzalez R. Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis. Pediatr Infect Dis J 1999; 18:647-649.
39. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998; 17:880-885.
40. Melander E, Molstad S, Persson K, Hansson HB, Soderstrom M, Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis 1990; 17:834-838.
41. Dagan R, Givon N, Yagpusky P, et al. Effect of a 9-valent pneumococcal vaccine on nasopharyngeal carriage of vaccine type and non-vaccine type S. pneumoniae strains among day care center attendees [Abstract G-521. In: Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego. Washington, DC: American Society for Microbiology, 1998.
42. Mbelle N, Huebner RE, Wasas AD, et al. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180:1171-1176.
43. Obarro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination [Letter]. Lancet 1996; 348:271.
44. Giebink GS. The prevention of pneumococcal disease in children. N Engl J Med 2001; 345:1177-1183.
45. Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks-Walter A. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 2000; 19(suppl 1):S87-S95.